What is the minimum investment required for PCD Pharma Franchise?

The minimum investment typically ranges from ₹2–5 lakhs, depending on territory size, product selection and initial stock planning. Our team will help structure this based on your goals.

What documents are required to become a franchise partner?

You will need a valid Drug License, GST registration and basic KYC documents. Our team will guide you through every step of the documentation process.

What kind of support and training do you provide?

We provide product training, sales guidance, marketing materials, doctor coverage strategies, and ongoing business support through dedicated account managers.

How are territories allocated and protected?

Territories are allocated based on mutual agreement and market mapping. We offer genuine monopoly rights with clear documentation to avoid internal competition.

What is the expected profit margin and ROI timeline?

Average profit margins range from 25–30%, with typical ROI timelines between 12–18 months, depending on your execution and territory potential.

How do you ensure product quality and compliance?

All products are manufactured in WHO-GMP certified facilities with 100% quality testing, robust documentation and DCGI approvals as applicable.

What is the delivery timeline and process?

Dispatch timelines depend on order size and location, but we maintain a strong track record of timely delivery across India with proper packaging and logistics partners.

Ampule

Emnil

Ondansetron Injection

Pack: 10x2ML
Format: Ampule

MRP₹13.35

A high-potency anti-emetic injection formulated for the rapid prevention and management of severe nausea and vomiting. Emnil contains Ondansetron, a selective 5-HT3 receptor antagonist designed to provide immediate relief in clinical and post-surgical settings.

About The Product

Key Benefits

Selective Serotonin Receptor Blockade

Ondansetron works by specifically blocking 5-HT3 receptors located both peripherally on vagal nerve terminals and centrally in the chemoreceptor trigger zone (CTZ) of the brain. This dual action effectively interrupts the signals that trigger the vomiting reflex.

Immediate Bioavailability for Acute Care

The injectable delivery ensures 100% absorption and immediate therapeutic plasma levels. This is critical for patients who are actively vomiting or unable to retain oral medications, providing swift stabilization in emergency or post-operative conditions.

Management of Chemotherapy-Induced Nausea

Emnil is a gold standard for preventing nausea and vomiting associated with emetogenic cancer chemotherapy. By blocking the release of serotonin from enterochromaffin cells in the small intestine, it significantly improves patient comfort during intensive treatments.

Post-Operative Recovery Support

Administered pre-operatively or during recovery, this injection prevents post-operative nausea and vomiting (PONV). This reduces the risk of surgical site strain and shortens recovery times by allowing patients to resume oral intake sooner.

Superior Safety and Tolerability

Unlike older anti-emetics, Ondansetron does not cause extrapyramidal side effects or significant sedation. This favorable safety profile makes it suitable for a wide range of patients, including those in critical care units.

Rapid and Sustained Relief

The formulation provides a rapid onset of action that lasts for several hours, ensuring that the patient remains protected from recurring episodes of nausea throughout the most critical phases of their treatment or recovery.

Indication Chemotherapy-Induced Nausea and Vomiting (CINV), Radiotherapy-Induced Nausea, Post-Operative Nausea and Vomiting (PONV), Severe Gastroenteritis, Drug-Induced Emesis, Prophylaxis in High-Risk Surgical Patients.

Indications

Chemotherapy-Induced Nausea and Vomiting (CINV)
Radiotherapy-Induced Nausea
Post-Operative Nausea and Vomiting (PONV)
Severe Gastroenteritis
Drug-Induced Emesis
Prophylaxis in High-Risk Surgical Patients.

Product descriptions, dosage forms, and compositions listed on the website are for reference by licensed practitioners and distributors only.

Emnil